


Triage & Monitoring : suPARnostic® helps identify critical cases early and aids in patient decisions - high and rising suPARnostic® level indicates a critical condition and increased risk of mortality, decreasing suPARnostic® indicates patient improvement and effective intervention.
A "Quick" test for suPAR - suPARnostic® Quick - , based on the widely used lateral flow test principle, is in validation at ViroGates and will add to the suPARnostic® product line soon, providing a quick rsik assessment for patients and health screening.
suPARnostic®'s can pinpoint developing acute conditions as well as increased long term risk at an early point in time, when other symptoms might not be notable and other blood tests have not reacted positively yet. Do you want to know if your suPAR level is in the normal range or elevated? Get tested. Read more...
Our suPARnostic® ELISA kit gets top marks from lab users: Performed in less than 2 hours, robust and yielding reproducible results, as we perform value transfer between batches. All reactions are at room temperature, all reagents are provided for convenience.
Great media attention on latest Press Release, now also in Norway....
![]()
Børsen article June 10, 2010
"Blodprøve spotter alvorlige sygdomme..." ![]()
Latest Press Release
Single blood test can predict severe diseases and mortality.... ![]()
New suPAR article accepted in Journal of Internal Medicine.... ![]()
BOP Innovation Day 2010
ViroGates and suPARnostic® case company for this years CBS/DIBD BOP Innovation Day....![]()
suPARnostic® partnered with new distributors
Electra-box in Denmark, Diagen in Norway and Teomed AG in Switzerland....
Now on LinkedIn:
Look for the suPARnostic® group on LinkedIn